The Family Firm’s Labcorp LH Stock Holding History

The Family Firm’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-184	Closed	-$37.5K	–	569
2024 Q2	$37.5K	Buy	+184	New	+$37.4K	0.01%	458

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

The Family Firm's LH Position: Q3 2024 in Review

The Family Firm sold out of Labcorp (LH) in Q3 2024, closing a stake of 184 shares — an estimated $37.5K sold.

The Family Firm first reported a position in LH in Q2 2024 and held it in 1 quarter. The position peaked at $37.5K in Q2 2024. 918 funds tracked by Wall St. Rank hold LH as of Q3 2024.

The Family Firm reported no remaining Labcorp position as of Q3 2024 after selling out during the quarter.
The Family Firm sold 184 Labcorp shares in Q3 2024, an estimated $37.5K.
The Family Firm first reported a position in Labcorp in Q2 2024 and held it in 1 quarter.
The Family Firm's Labcorp position peaked at $37.5K in Q2 2024.
918 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.